Key result
Adenosine is highlighted as a potentially first-choice drug for the acute termination of supraventricular tachycardia, characterized by transient effects and an ultra-short half-life.
Why the study?
Does adenosine acutely terminate supraventricular tachycardia?
Does adenosine acutely terminate supraventricular tachycardia?
Adenosine is highlighted as a potential first-choice drug for the acute termination of supraventricular tachycardia due to its efficacy and ultra-short half-life.
Adenosine may be considered for SVT termination; leaves open first-line status and diagnostic utility pending controlled trials.
Adenosine, recently released for the acute termination of supraventricular tachycardia, is potentially the drug of first choice for this indication. Its notable effects are transient slowing of the sinus rate and atrioventricular nodal block. Adverse effects are transient and clinically insignificant, primarily because of the ultra-short half-life of the drug. Preliminary investigations suggest that adenosine may also be useful in the differential diagnosis of wide QRS complex tachycardias.
No takes yet. Share an insight, caveat, or question.
Vidt et al. (1990) conducted a review in Supraventricular tachycardia. Adenosine was evaluated. Adenosine is highlighted as a potentially first-choice drug for the acute termination of supraventricular tachycardia, characterized by transient effects and an ultra-short half-life.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: